SEATTLE, March 16, 2011 (GLOBE NEWSWIRE) -- The article (http://www.cpreports.com/?p=931), written by respected business writer Gene Marcial, provides insights into recent progress of TapImmune Inc. (OTCBB:TPIV), its research and development collaborations and the status of the Company's product portfolio.
